Loading...
SCD logo

Zentiva S.A.BVB:SCD Stock Report

Market Cap RON 3.2b
Share Price
n/a
1Y55.9%
7D0%
1D2.3%
Portfolio Value
​
View

Zentiva S.A.

BVB:SCD Stock Report

Market Cap: RON 3.2b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Zentiva (SCD) Stock Overview

Engages in the production and marketing of preparations and medicines for human use in Romania and internationally. More details

SCD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Rewards

Price-To-Earnings ratio (11.6x) is below the RO market (13.3x)

Earnings grew by 42.7% over the past year

Risk Analysis

Shares are highly illiquid


SCD Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW489,733 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
AG
Agricola
489,733 investors already sharing narratives
View all narratives

Zentiva S.A. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Zentiva
Historical stock prices
Current Share PriceRON 4.52
52 Week HighRON 4.60
52 Week LowRON 2.82
Beta0.35
1 Month Change0%
3 Month Change2.26%
1 Year Change55.86%
3 Year Change115.24%
5 Year Change46.75%
Change since IPO9,000.06%

Recent News & Updates

Analysis Article • Jul 30

Take Care Before Diving Into The Deep End On Zentiva S.A. (BVB:SCD)

When close to half the companies in Romania have price-to-earnings ratios (or "P/E's") above 17x, you may consider...

Recent updates

Analysis Article • Jul 30

Take Care Before Diving Into The Deep End On Zentiva S.A. (BVB:SCD)

When close to half the companies in Romania have price-to-earnings ratios (or "P/E's") above 17x, you may consider...
Analysis Article • Mar 02

Zentiva S.A. (BVB:SCD) Doing What It Can To Lift Shares

There wouldn't be many who think Zentiva S.A.'s ( BVB:SCD ) price-to-earnings (or "P/E") ratio of 11.6x is worth a...
Analysis Article • May 24

Zentiva's (BVB:SCD) Solid Earnings May Rest On Weak Foundations

The recent earnings posted by Zentiva S.A. ( BVB:SCD ) were solid, but the stock didn't move as much as we expected. We...
Analysis Article • Mar 01

Zentiva (BVB:SCD) Has Gifted Shareholders With A Fantastic 201% Total Return On Their Investment

Passive investing in index funds can generate returns that roughly match the overall market. But the truth is, you can...
Analysis Article • Jan 25

Zentiva S.A.'s (BVB:SCD) Stock Is Going Strong: Have Financials A Role To Play?

Most readers would already be aware that Zentiva's (BVB:SCD) stock increased significantly by 11% over the past three...
Analysis Article • Dec 18

Zentiva S.A. (BVB:SCD) Investors Are Less Pessimistic Than Expected

When close to half the companies in Romania have price-to-earnings ratios (or "P/E's") below 12x, you may consider...

Shareholder Returns

SCDRO PharmaceuticalsRO Market
7D0%-3.9%0.1%
1Y55.9%14.8%73.1%

Return vs Industry: SCD exceeded the RO Pharmaceuticals industry which returned -3.4% over the past year.

Return vs Market: SCD exceeded the RO Market which returned 7.1% over the past year.

Price Volatility

Is SCD's price volatile compared to industry and market?
SCD volatility
SCD Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement4.9%
10% most volatile stocks in RO Market12.4%
10% least volatile stocks in RO Market2.7%

Stable Share Price: SCD's share price has been volatile over the past 3 months compared to the RO market.

Volatility Over Time: Insufficient data to determine SCD's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19621,035Simona Cocoswww.zentiva.ro

Zentiva S.A. engages in the production and marketing of preparations and medicines for human use in Romania and internationally. The company develops pharmaceutical products in various therapeutic areas, such as cardiovascular diseases, anti-inflammatory and pain-relieving medications, urologists, blood diseases, gastrointestinal and metabolic disorders, central nervous system, infections, respiratory systems, and other. It also offers educational materials for healthcare professionals and patients.

Zentiva S.A. Fundamentals Summary

How do Zentiva's earnings and revenue compare to its market cap?
SCD fundamental statistics
Market capRON 3.15b
Earnings (TTM)RON 270.78m
Revenue (TTM)RON 1.09b
11.6x
P/E Ratio
2.9x
P/S Ratio

Is SCD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SCD income statement (TTM)
RevenueRON 1.09b
Cost of RevenueRON 470.10m
Gross ProfitRON 623.98m
Other ExpensesRON 353.20m
EarningsRON 270.78m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.39
Gross Margin57.03%
Net Profit Margin24.75%
Debt/Equity Ratio0%

How did SCD perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/17 09:50
End of Day Share Price 2024/11/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zentiva S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.